Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Macroangiopathy in adults and children with diabetes: risk factors (part 2).

Di Marzio D, Mohn A, de Martino M, Chiarelli F.

Horm Metab Res. 2006 Nov;38(11):706-20. Review.

PMID:
17111297
2.

Macroangiopathy in adults and children with diabetes: from molecular mechanisms to vascular damage (part 1).

Di Marzio D, Mohn A, Mokini ZH, Giannini C, Chiarelli F.

Horm Metab Res. 2006 Nov;38(11):691-705. Review.

PMID:
17111296
3.

Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus.

Guerci B, Böhme P, Kearney-Schwartz A, Zannad F, Drouin P.

Diabetes Metab. 2001 Sep;27(4 Pt 1):436-47. Review.

PMID:
11547217
4.

Role of postprandial hyperglycaemia in cardiovascular disease in diabetes.

Yamagishi SI, Nakamura K, Matsui T, Ueda SI, Imaizumi T.

Int J Clin Pract. 2007 Jan;61(1):83-7. Review.

PMID:
17229182
5.

Endothelial dysfunction and type 2 diabetes. Part 1: physiology and methods for exploring the endothelial function.

Guerci B, Kearney-Schwartz A, Böhme P, Zannad F, Drouin P.

Diabetes Metab. 2001 Sep;27(4 Pt 1):425-34. Review.

PMID:
11547216
6.

Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis.

Rahman S, Rahman T, Ismail AA, Rashid AR.

Diabetes Obes Metab. 2007 Nov;9(6):767-80. Review.

PMID:
17924861
7.

Prevalence of macrovascular complications and cardiovascular risk factors in people treated for diabetes and living in France: the ENTRED study 2001.

Romon I, Fosse S, Eschwège E, Simon D, Weill A, Varroud-Vial M, Detournay B, Fagot-Campagna A.

Diabetes Metab. 2008 Apr;34(2):140-7. doi: 10.1016/j.diabet.2007.11.002. Epub 2008 Mar 4.

PMID:
18304854
8.

Stroke prevention in diabetes and obesity.

Kurukulasuriya LR, Govindarajan G, Sowers J.

Expert Rev Cardiovasc Ther. 2006 Jul;4(4):487-502. Review.

PMID:
16918267
9.

Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia.

Milicevic Z, Raz I, Beattie SD, Campaigne BN, Sarwat S, Gromniak E, Kowalska I, Galic E, Tan M, Hanefeld M.

Diabetes Care. 2008 Feb;31 Suppl 2:S155-60. doi: 10.2337/dc08-s240. Review.

PMID:
18227478
10.

[Cardiovascular disease in diabetes mellitus: classical and non-classical risk factors].

Siqueira AF, Almeida-Pititto Bd, Ferreira SR.

Arq Bras Endocrinol Metabol. 2007 Mar;51(2):257-67. Review. Portuguese.

11.

Primary prevention of cardiovascular disease in people with dysglycemia.

Bianchi C, Miccoli R, Penno G, Del Prato S.

Diabetes Care. 2008 Feb;31 Suppl 2:S208-14. doi: 10.2337/dc08-s256. Review.

PMID:
18227487
12.

Macrovascular angiopathy in children and adolescents with type 1 diabetes.

Giannini C, Mohn A, Chiarelli F, Kelnar CJ.

Diabetes Metab Res Rev. 2011 Jul;27(5):436-60. doi: 10.1002/dmrr.1195. Review.

PMID:
21433262
13.

Adiponectin gene and cardiovascular risk in type 2 diabetic patients: a review of evidences.

Ferrarezi DA, Cheurfa N, Reis AF, Fumeron F, Velho G.

Arq Bras Endocrinol Metabol. 2007 Mar;51(2):153-9. Review.

14.
15.

[Atherothrombosis in patients with type 2 diabetes mellitus: an overview of pathophysiology].

Mafrici A, Proietti R.

G Ital Cardiol (Rome). 2010 Jun;11(6):467-77. Review. Italian.

PMID:
20922872
16.

[Dyslipidemias in type 1 diabetes: a current approach].

Matheus AS, Cobas RA, Gomes MB.

Arq Bras Endocrinol Metabol. 2008 Mar;52(2):334-9. Portuguese.

17.

Diabetic nephropathy in 27,805 children, adolescents, and adults with type 1 diabetes: effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex.

Raile K, Galler A, Hofer S, Herbst A, Dunstheimer D, Busch P, Holl RW.

Diabetes Care. 2007 Oct;30(10):2523-8. Epub 2007 Jul 13.

PMID:
17630266
18.

Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets.

Potenza MA, Gagliardi S, Nacci C, Carratu' MR, Montagnani M.

Curr Med Chem. 2009;16(1):94-112. Review.

PMID:
19149564
19.

Novel cardiovascular risk factors and macrovascular and microvascular complications of diabetes.

Theuma P, Fonseca VA.

Curr Drug Targets. 2003 Aug;4(6):477-86. Review.

PMID:
12866662
20.

Retinopathy in type 2 diabetes mellitus is associated with increased intima-media thickness and endothelial dysfunction.

Malecki MT, Osmenda G, Walus-Miarka M, Skupien J, Cyganek K, Mirkiewicz-Sieradzka B, damek-Guzik TA, Guzik TJ, Sieradzki J.

Eur J Clin Invest. 2008 Dec;38(12):925-30. doi: 10.1111/j.1365-2362.2008.02051.x.

PMID:
19021717

Supplemental Content

Support Center